Drug therapy for PKU reverses he... ( A pricy drug used to treat a rare bu...)

Drug therapy for PKU reverses heart damage

Date:5/13/2008

A pricy drug used to treat a rare but well-known genetic disorder may hold wider promise as a treatment for millions of Americans with potentially lethal enlarged hearts, due mainly to high blood pressure, a study from Johns Hopkins shows.

The common denominator in both phenylketonuria (PKU) and cardiac hypertrophy is the chemical tetrahydrobiopterin (BH4). In PKU, this enzyme coworker helps break down the molecule phenylalanine whose buildup is toxic to the brain. In the heart, BH4 helps build the chemical nitric oxide, which is needed for normal heart function and neutralizing toxic chemicals, called oxygen free radicals.

Doctors have used BH4 and diets that exclude phenylalanine for almost a decade to treat PKU, a so-called inborn error of metabolism that if left untreated causes irreversible brain damage. It affects an estimated 15,000 newborns in the United States each year.

Building on what has been known about BH4s activities, the Hopkins team, working with mice, found that treatment with BH4 stabilizes the pumping function of failing, enlarged hearts and dramatically shrinks the muscle size in a relatively short timeframe of just over a month. The teams findings appear in the May 20 edition of the journal Circulation.

Our results show for the first time the pivotal role played by BH4 in stopping and reversing the weakening and damage done even in severe cases to the heart muscle as a result of hypertension and subsequent hypertrophy, says study senior investigator David Kass, M.D., a professor at the Johns Hopkins University School of Medicine and its Heart Institute. This key evidence may help us develop new therapies that stop and reverse hypertrophy, preventing the disease from leading to end-stage heart failure and keeping affected individuals from needing heart-assist pumps or a treatment of last resort, the heart transplant.

Specifically, Kass and Belgian scientist, An Moens, M.D., a postdo
'/>"/>

Contact: David March
dmarch1@jhmi.edu
410-955-1534
Johns Hopkins Medical Institutions
Source:Eurekalert

0

GOOD

Page: 1 2 3 4
Related medicine news :

1. Vision restoration therapy shown to improve brain activity in brain injured patients
2. HIV therapy in pregnancy-data support WHO recommendations
3. Family-based treatment more effective than supportive psychotherapy in treating bulimia
4. Trial to Test Gene Therapy for Angina in Women
5. One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High
6. Aromatherapy Gift Line Sheds Humorous Light on Modern Therapy
7. Chemotherapy may be culprit for fatigue in breast cancer survivors
8. Atlanta Falcons Physical Therapy Centers Set to Launch This Fall
9. New Drug No Substitute for Standard Blood-Clot Therapy
10. Stem Cell Therapy Disappoints Against Rare Kidney Ailment
11. Nucletron Announces Management Buy-Out to More Effectively Meet the Demands of Its Customers and the Radiation Therapy Community

Post Your Comments:

(Date:5/21/2013)... 2013 Adeptia, a leading provider of ... announced it is the featured company in an impact ... The report, “Adeptia Bets on Converged Cloud Integration and ... its strategy, products, pricing, customers and competition. ... framework for integration and process orchestration, especially when price, ...

(Date:5/21/2013)... News) -- Chronic obstructive pulmonary disease (COPD) patients ... suggests. Pain levels are nearly on par ... osteoarthritis and rheumatoid arthritis patients, according to the ... the American Thoracic Society annual meeting in Philadelphia. ... pain medication use among COPD patients, and pain ...

(Date:5/21/2013)... 21 (HealthDay News) -- The risk of sudden infant ... sleep with their infant, a new study finds. ... SIDS even if parents do not drink, use illegal ... which is a major cause of infant death in ... sleep with their babies. In the United States, ...

(Date:5/21/2013)... News) -- The monstrous tornado that devastated Moore, ... children, is a stunning example of violent weather ... But even thunderstorms with lightning and strong winds ... Some anxiety in the face of ... storm phobias that interfere with their everyday lives, ...

(Date:5/21/2013)... charged gold nanoparticles are usually toxic to cells, ... toxicity. Mayo Clinic researchers found out why, and ... ovarian cancer cells. The discovery is detailed in ... of Biological Chemistry ., "This study identifies a ... preventing the cell death or apoptosis which should ...

Breaking Medicine News(10 mins):Health News:Adeptia Featured in Recent 451 Research Impact Report 2 Health News:Pain a Common Problem for People With COPD 2 Health News:Bed-Sharing Raises SIDS Risk Fivefold, Study Finds 2 Health News:Weather Worries Can Threaten a Child's Mental Health 2 Health News:Mayo Clinic: How gold nanoparticles can help fight ovarian cancer 2

[0] Adeptia Featured in Recent 451 Research Impact Report [0] Pain a Common Problem for People With COPD [0] Bed-Sharing Raises SIDS Risk Fivefold, Study Finds [0] Weather Worries Can Threaten a Child's Mental Health [0] Mayo Clinic: How gold nanoparticles can help fight ovarian cancer

... most previous work missed key DNA variant, researchers say ... structural changes in DNA called copy number variants may ... who said their findings support a sharp change of ... the past two decades, researchers have identified dozens of ...

... Corporate Governance,TUCSON, Ariz., Feb. 6 The Providence Service ... the recent announcement that an entity controlled by Avalon ... related persons, including Donald E. Smith, the CEO, controlling ... a consent solicitation against the Company. "We have no ...

... EVVV ) will release its 2008 fourth quarter ... on Tuesday, Febuary 24, 2009, before regular market trading hours.The ... day at 7:30 a.m. Central Time (8:30 a.m. Eastern Time). ... operating results and future outlook, followed by a question and ...

... year-to-date revenues increase by 35% over same period ... figures are in Canadian dollars unless otherwise noted),BELLEVILLE, ... Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical ... quarter of its 2009 fiscal year, ending December ...

... The rate of childhood obesity has risen significantly in ... younger ages. At the same time, the number of ... Now a new study finds that, contrary to conventional ... they,re playing outside. , The study, by an interdisciplinary ...

... view simulated results of breast enlargement in 3D, with accurate linear ... ... 5, 2009 -- Toronto Cosmetic Clinic introduces Axis Three,s Portrait 3D ... predicted results of breast augmentation almost instantaneously. ...

Genome Study Points to New Culprit for Schizophrenia Providence Service Corporation Comments on Consent Solicitation by Avalon Correctional Services, Inc.ev3 Inc. to Report 2008 Fourth Quarter and Full-Year Financial Results and Host Conference Call on February 24, 2009 Bioniche Reports Fiscal 2009 Second Quarter Amid rising childhood obesity, preschoolers found to be inactive Toronto Cosmetic Clinic Offers Axis Three Breast Enlargement Imaging for the First Time in Canada

(Date:5/21/2013)... May 21, 2013 Reportlinker.com announces ... available in its catalogue: ... Scenario for Medical Devices in the US ... Changing Regulatory and Reimbursement ... Market Summary ...

(Date:5/21/2013)... Calif. , May 21, 2013 /PRNewswire/ ... ), a specialty pharmaceutical company focused on ... for the treatment of acute and breakthrough ... in a placebo-controlled Phase 3 study of ... analgesia) System (NanoTab System), the primary efficacy ...

(Date:5/21/2013)... and HENDERSONVILLE, N.C. , May ... procurement program for home medical equipment is forcing ... Carolina to lay off employees or close ... of service and products received by Medicare beneficiaries, says ... defective and dangerous program, the Centers for Medicare ...

[0] Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market [0] Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain [0] North Carolina Business Owners At Risk Because Of Defective Medicare Bidding Program

... CareFusion today announced an agreement to acquire PHACTS, ... hospital pharmacies better manage inventory, reduce pharmaceutical costs and ... The acquisition will advance CareFusion,s strategy to ... medication throughout their facilities – from the loading ...

... /PRNewswire-Asia/ -- At this very moment, FIRMOO is being heatedly ... of eyeglasses from FIRMOO are being delivered to various countries ... by so many eyeglasses wearers? In this brand new year ... sales platforms, is giving away thousands of free eyeglasses every ...

Cached Medicine Technology:CareFusion To Acquire Pharmacy Automation Technology Leader 2 CareFusion To Acquire Pharmacy Automation Technology Leader 3 CareFusion To Acquire Pharmacy Automation Technology Leader 4 Free Glasses from FIRMOO - Welcome to Your Glasses Kingdom 2 Free Glasses from FIRMOO - Welcome to Your Glasses Kingdom 3

CareFusion To Acquire Pharmacy Automation Technology Leader Free Glasses from FIRMOO - Welcome to Your Glasses Kingdom

Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....

For use with catalog #0454....

Immuno-turbidimetric Assay of D-Dimer by STA© Analyzers. Microlatex particles coated with two different mouse monoclonal anti-human D-Dimer antibodies....

Medicine Products:

Drugs of Abuse Array Cocaine Metabolite Assay D-DI TEST CARDS D-DI LATEX STA LIATEST D-DI